Where Will ISRG Stock Be in 5 Years?
Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…
Sell
50
MEDP Quote, Financials, Valuation and Earnings
Last price:
$602.36
Seasonality move
:
-1.49%
Day range:
$588.00 - $605.33
52-week range:
$250.05 - $628.92
Dividend yield:
0%
P/E ratio:
42.11x
P/S ratio:
7.72x
P/B ratio:
57.75x
Volume:
205.1K
Avg. volume:
212.1K
1-year change:
74.98%
Market cap:
$17B
Revenue:
$2.1B
EPS (TTM):
$14.30
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
MEDP
Medpace Holdings, Inc.
|
$689.5M | $4.20 | 21.57% | 14.5% | $545.75 |
|
BSX
Boston Scientific Corp.
|
$5.3B | $0.78 | 11.57% | 76.14% | $124.41 |
|
BTSG
BrightSpring Health Services, Inc.
|
$3.4B | $0.34 | 15.11% | 82.09% | $43.47 |
|
IQV
IQVIA Holdings, Inc.
|
$4.2B | $3.40 | 6.51% | 110.55% | $261.15 |
|
ISRG
Intuitive Surgical, Inc.
|
$2.8B | $2.27 | 16.15% | 10.92% | $608.55 |
|
SGHT
Sight Sciences, Inc.
|
$20.4M | -$0.16 | 10.26% | -36.3% | $9.35 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
MEDP
Medpace Holdings, Inc.
|
$602.06 | $545.75 | $17B | 42.11x | $0.00 | 0% | 7.72x |
|
BSX
Boston Scientific Corp.
|
$93.55 | $124.41 | $138.7B | 50.04x | $0.00 | 0% | 7.22x |
|
BTSG
BrightSpring Health Services, Inc.
|
$40.09 | $43.47 | $7.2B | 66.92x | $0.00 | 0% | 0.70x |
|
IQV
IQVIA Holdings, Inc.
|
$239.43 | $261.15 | $40.8B | 32.87x | $0.00 | 0% | 2.65x |
|
ISRG
Intuitive Surgical, Inc.
|
$528.81 | $608.55 | $187.5B | 67.10x | $0.00 | 0% | 19.06x |
|
SGHT
Sight Sciences, Inc.
|
$6.05 | $9.35 | $319.9M | -- | $0.00 | 0% | 4.10x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
MEDP
Medpace Holdings, Inc.
|
32.9% | 1.310 | 0.99% | 0.51x |
|
BSX
Boston Scientific Corp.
|
33.99% | 0.384 | 8.31% | 0.81x |
|
BTSG
BrightSpring Health Services, Inc.
|
59.75% | 3.360 | 50.52% | 0.74x |
|
IQV
IQVIA Holdings, Inc.
|
71.15% | 1.035 | 46.77% | 0.62x |
|
ISRG
Intuitive Surgical, Inc.
|
-- | 1.051 | -- | 3.42x |
|
SGHT
Sight Sciences, Inc.
|
38.76% | 0.678 | 22.54% | 8.65x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
MEDP
Medpace Holdings, Inc.
|
$189.9M | $141.8M | 61.64% | 78.26% | 21.49% | $235.5M |
|
BSX
Boston Scientific Corp.
|
$3.3B | $1B | 8.19% | 12.46% | 20.55% | $1.2B |
|
BTSG
BrightSpring Health Services, Inc.
|
$392M | $105.5M | 1.57% | 4.14% | 3.17% | $92.2M |
|
IQV
IQVIA Holdings, Inc.
|
$1.1B | $572M | 6.13% | 20.65% | 13.96% | $772M |
|
ISRG
Intuitive Surgical, Inc.
|
$1.9B | $864.3M | 16.57% | 16.59% | 30.16% | $735.6M |
|
SGHT
Sight Sciences, Inc.
|
$17.2M | -$7.9M | -38.96% | -58.45% | -39.71% | -$8.9M |
Medpace Holdings, Inc. vs. Competitors
-
Which has Higher Returns MEDP or BSX?
Boston Scientific Corp. has a net margin of 16.84% compared to Medpace Holdings, Inc.'s net margin of 14.91%. Medpace Holdings, Inc.'s return on equity of 78.26% beat Boston Scientific Corp.'s return on equity of 12.46%.
Company Gross Margin Earnings Per Share Invested Capital MEDPMedpace Holdings, Inc.28.78% $3.86 $437.6M BSXBoston Scientific Corp.65.31% $0.50 $35.7B -
What do Analysts Say About MEDP or BSX?
Medpace Holdings, Inc. has a consensus price target of $545.75, signalling downside risk potential of -9.35%. On the other hand Boston Scientific Corp. has an analysts' consensus of $124.41 which suggests that it could grow by 32.98%. Given that Boston Scientific Corp. has higher upside potential than Medpace Holdings, Inc., analysts believe Boston Scientific Corp. is more attractive than Medpace Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MEDPMedpace Holdings, Inc.1 8 3 BSXBoston Scientific Corp.26 1 0 -
Is MEDP or BSX More Risky?
Medpace Holdings, Inc. has a beta of 1.431, which suggesting that the stock is 43.061% more volatile than S&P 500. In comparison Boston Scientific Corp. has a beta of 0.670, suggesting its less volatile than the S&P 500 by 33.029%.
-
Which is a Better Dividend Stock MEDP or BSX?
Medpace Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medpace Holdings, Inc. pays -- of its earnings as a dividend. Boston Scientific Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MEDP or BSX?
Medpace Holdings, Inc. quarterly revenues are $659.9M, which are smaller than Boston Scientific Corp. quarterly revenues of $5.1B. Medpace Holdings, Inc.'s net income of $111.1M is lower than Boston Scientific Corp.'s net income of $755M. Notably, Medpace Holdings, Inc.'s price-to-earnings ratio is 42.11x while Boston Scientific Corp.'s PE ratio is 50.04x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medpace Holdings, Inc. is 7.72x versus 7.22x for Boston Scientific Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MEDPMedpace Holdings, Inc.7.72x 42.11x $659.9M $111.1M BSXBoston Scientific Corp.7.22x 50.04x $5.1B $755M
-
Which has Higher Returns MEDP or BTSG?
BrightSpring Health Services, Inc. has a net margin of 16.84% compared to Medpace Holdings, Inc.'s net margin of 1.12%. Medpace Holdings, Inc.'s return on equity of 78.26% beat BrightSpring Health Services, Inc.'s return on equity of 4.14%.
Company Gross Margin Earnings Per Share Invested Capital MEDPMedpace Holdings, Inc.28.78% $3.86 $437.6M BTSGBrightSpring Health Services, Inc.11.76% $0.26 $4.5B -
What do Analysts Say About MEDP or BTSG?
Medpace Holdings, Inc. has a consensus price target of $545.75, signalling downside risk potential of -9.35%. On the other hand BrightSpring Health Services, Inc. has an analysts' consensus of $43.47 which suggests that it could grow by 8.42%. Given that BrightSpring Health Services, Inc. has higher upside potential than Medpace Holdings, Inc., analysts believe BrightSpring Health Services, Inc. is more attractive than Medpace Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MEDPMedpace Holdings, Inc.1 8 3 BTSGBrightSpring Health Services, Inc.14 0 0 -
Is MEDP or BTSG More Risky?
Medpace Holdings, Inc. has a beta of 1.431, which suggesting that the stock is 43.061% more volatile than S&P 500. In comparison BrightSpring Health Services, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MEDP or BTSG?
Medpace Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. BrightSpring Health Services, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medpace Holdings, Inc. pays -- of its earnings as a dividend. BrightSpring Health Services, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MEDP or BTSG?
Medpace Holdings, Inc. quarterly revenues are $659.9M, which are smaller than BrightSpring Health Services, Inc. quarterly revenues of $3.3B. Medpace Holdings, Inc.'s net income of $111.1M is higher than BrightSpring Health Services, Inc.'s net income of $37.5M. Notably, Medpace Holdings, Inc.'s price-to-earnings ratio is 42.11x while BrightSpring Health Services, Inc.'s PE ratio is 66.92x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medpace Holdings, Inc. is 7.72x versus 0.70x for BrightSpring Health Services, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MEDPMedpace Holdings, Inc.7.72x 42.11x $659.9M $111.1M BTSGBrightSpring Health Services, Inc.0.70x 66.92x $3.3B $37.5M
-
Which has Higher Returns MEDP or IQV?
IQVIA Holdings, Inc. has a net margin of 16.84% compared to Medpace Holdings, Inc.'s net margin of 8.1%. Medpace Holdings, Inc.'s return on equity of 78.26% beat IQVIA Holdings, Inc.'s return on equity of 20.65%.
Company Gross Margin Earnings Per Share Invested Capital MEDPMedpace Holdings, Inc.28.78% $3.86 $437.6M IQVIQVIA Holdings, Inc.26.49% $1.93 $21.5B -
What do Analysts Say About MEDP or IQV?
Medpace Holdings, Inc. has a consensus price target of $545.75, signalling downside risk potential of -9.35%. On the other hand IQVIA Holdings, Inc. has an analysts' consensus of $261.15 which suggests that it could grow by 9.07%. Given that IQVIA Holdings, Inc. has higher upside potential than Medpace Holdings, Inc., analysts believe IQVIA Holdings, Inc. is more attractive than Medpace Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MEDPMedpace Holdings, Inc.1 8 3 IQVIQVIA Holdings, Inc.16 5 0 -
Is MEDP or IQV More Risky?
Medpace Holdings, Inc. has a beta of 1.431, which suggesting that the stock is 43.061% more volatile than S&P 500. In comparison IQVIA Holdings, Inc. has a beta of 1.364, suggesting its more volatile than the S&P 500 by 36.392%.
-
Which is a Better Dividend Stock MEDP or IQV?
Medpace Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IQVIA Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medpace Holdings, Inc. pays -- of its earnings as a dividend. IQVIA Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MEDP or IQV?
Medpace Holdings, Inc. quarterly revenues are $659.9M, which are smaller than IQVIA Holdings, Inc. quarterly revenues of $4.1B. Medpace Holdings, Inc.'s net income of $111.1M is lower than IQVIA Holdings, Inc.'s net income of $332M. Notably, Medpace Holdings, Inc.'s price-to-earnings ratio is 42.11x while IQVIA Holdings, Inc.'s PE ratio is 32.87x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medpace Holdings, Inc. is 7.72x versus 2.65x for IQVIA Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MEDPMedpace Holdings, Inc.7.72x 42.11x $659.9M $111.1M IQVIQVIA Holdings, Inc.2.65x 32.87x $4.1B $332M
-
Which has Higher Returns MEDP or ISRG?
Intuitive Surgical, Inc. has a net margin of 16.84% compared to Medpace Holdings, Inc.'s net margin of 27.89%. Medpace Holdings, Inc.'s return on equity of 78.26% beat Intuitive Surgical, Inc.'s return on equity of 16.59%.
Company Gross Margin Earnings Per Share Invested Capital MEDPMedpace Holdings, Inc.28.78% $3.86 $437.6M ISRGIntuitive Surgical, Inc.66.56% $2.21 $17.9B -
What do Analysts Say About MEDP or ISRG?
Medpace Holdings, Inc. has a consensus price target of $545.75, signalling downside risk potential of -9.35%. On the other hand Intuitive Surgical, Inc. has an analysts' consensus of $608.55 which suggests that it could grow by 15.08%. Given that Intuitive Surgical, Inc. has higher upside potential than Medpace Holdings, Inc., analysts believe Intuitive Surgical, Inc. is more attractive than Medpace Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MEDPMedpace Holdings, Inc.1 8 3 ISRGIntuitive Surgical, Inc.14 11 1 -
Is MEDP or ISRG More Risky?
Medpace Holdings, Inc. has a beta of 1.431, which suggesting that the stock is 43.061% more volatile than S&P 500. In comparison Intuitive Surgical, Inc. has a beta of 1.669, suggesting its more volatile than the S&P 500 by 66.867%.
-
Which is a Better Dividend Stock MEDP or ISRG?
Medpace Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Intuitive Surgical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medpace Holdings, Inc. pays -- of its earnings as a dividend. Intuitive Surgical, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MEDP or ISRG?
Medpace Holdings, Inc. quarterly revenues are $659.9M, which are smaller than Intuitive Surgical, Inc. quarterly revenues of $2.9B. Medpace Holdings, Inc.'s net income of $111.1M is lower than Intuitive Surgical, Inc.'s net income of $799.5M. Notably, Medpace Holdings, Inc.'s price-to-earnings ratio is 42.11x while Intuitive Surgical, Inc.'s PE ratio is 67.10x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medpace Holdings, Inc. is 7.72x versus 19.06x for Intuitive Surgical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MEDPMedpace Holdings, Inc.7.72x 42.11x $659.9M $111.1M ISRGIntuitive Surgical, Inc.19.06x 67.10x $2.9B $799.5M
-
Which has Higher Returns MEDP or SGHT?
Sight Sciences, Inc. has a net margin of 16.84% compared to Medpace Holdings, Inc.'s net margin of -41.04%. Medpace Holdings, Inc.'s return on equity of 78.26% beat Sight Sciences, Inc.'s return on equity of -58.45%.
Company Gross Margin Earnings Per Share Invested Capital MEDPMedpace Holdings, Inc.28.78% $3.86 $437.6M SGHTSight Sciences, Inc.86.39% -$0.16 $105M -
What do Analysts Say About MEDP or SGHT?
Medpace Holdings, Inc. has a consensus price target of $545.75, signalling downside risk potential of -9.35%. On the other hand Sight Sciences, Inc. has an analysts' consensus of $9.35 which suggests that it could grow by 54.55%. Given that Sight Sciences, Inc. has higher upside potential than Medpace Holdings, Inc., analysts believe Sight Sciences, Inc. is more attractive than Medpace Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MEDPMedpace Holdings, Inc.1 8 3 SGHTSight Sciences, Inc.3 3 0 -
Is MEDP or SGHT More Risky?
Medpace Holdings, Inc. has a beta of 1.431, which suggesting that the stock is 43.061% more volatile than S&P 500. In comparison Sight Sciences, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MEDP or SGHT?
Medpace Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Sight Sciences, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medpace Holdings, Inc. pays -- of its earnings as a dividend. Sight Sciences, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MEDP or SGHT?
Medpace Holdings, Inc. quarterly revenues are $659.9M, which are larger than Sight Sciences, Inc. quarterly revenues of $19.9M. Medpace Holdings, Inc.'s net income of $111.1M is higher than Sight Sciences, Inc.'s net income of -$8.2M. Notably, Medpace Holdings, Inc.'s price-to-earnings ratio is 42.11x while Sight Sciences, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medpace Holdings, Inc. is 7.72x versus 4.10x for Sight Sciences, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MEDPMedpace Holdings, Inc.7.72x 42.11x $659.9M $111.1M SGHTSight Sciences, Inc.4.10x -- $19.9M -$8.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Kratos Stock a Good Investment?
UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…
Is Palantir Stock Going to Crash?
AI and data analytics major Palantir (NASDAQ:PLTR) has become something…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
50
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
52
CVLT alert for Jan 27
Commvault Systems, Inc. [CVLT] is down 31.22% over the past day.
Buy
73
BNAI alert for Jan 27
Brand Engagement Network, Inc. [BNAI] is down 16.85% over the past day.
Buy
71
SANM alert for Jan 27
Sanmina Corp. [SANM] is down 21.58% over the past day.
